GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Center Laboratories 4123.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

28.40

+0.71%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.52bn

FY2016FY2025

Net income

TWD 9.32bn

FY2016FY2025

Free cash flow

−TWD 181.1m

FY2016FY2025

Shareholders' equity

TWD 26.49bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.52bnTWD 1.62bnTWD 1.39bnTWD 767.7mTWD 500.1mTWD 717.0mTWD 1.44bnTWD 21.65bnTWD 19.39bnTWD 15.04bn
Gross profitTWD 621.3mTWD 749.0mTWD 618.1mTWD 406.3mTWD 259.7mTWD 350.3mTWD 619.7mTWD 10.33bnTWD 8.45bnTWD 6.25bn
Research and developmentTWD 84.8mTWD 72.0mTWD 82.8mTWD 47.0mTWD 75.4mTWD 128.9mTWD 206.3mTWD 732.4mTWD 805.6mTWD 518.0m
Operating income—TWD 234.3m−TWD 79.3mTWD 131.9mTWD 1.05bnTWD 372.7mTWD 198.2mTWD 1.39bnTWD 888.0mTWD 429.6m
Net incomeTWD 9.32bn−TWD 1.10bn−TWD 1.05bn−TWD 575.6mTWD 1.82bnTWD 3.79bn−TWD 203.6mTWD 6.08bnTWD 250.0mTWD 19.5m
Diluted earnings per share11.89-1.58-1.53-0.883.006.60-0.3611.680.490.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 34.63bnTWD 25.54bnTWD 27.00bnTWD 25.19bnTWD 30.44bnTWD 27.87bnTWD 22.87bnTWD 20.38bnTWD 38.30bnTWD 30.35bn
Cash and short-term investments——TWD 4.55bnTWD 2.56bnTWD 5.09bnTWD 1.17bnTWD 1.17bnTWD 1.49bnTWD 9.20bnTWD 8.89bn
Total liabilitiesTWD 8.14bnTWD 7.48bnTWD 6.79bnTWD 5.94bnTWD 9.35bnTWD 7.23bnTWD 7.41bnTWD 4.91bnTWD 21.43bnTWD 14.53bn
DebtTWD 1.77bnTWD 6.53bnTWD 5.62bnTWD 3.47bnTWD 5.27bnTWD 3.77bnTWD 4.37bnTWD 2.86bnTWD 12.32bnTWD 8.81bn
Shareholders' equityTWD 26.49bnTWD 18.05bnTWD 19.76bnTWD 19.25bnTWD 18.94bnTWD 17.98bnTWD 13.27bnTWD 13.07bnTWD 6.80bnTWD 6.79bn
Shares outstanding784m700m686m654m606m573m566m521m508m515m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 27.2mTWD 394.7m−TWD 963.4m−TWD 189.9m−TWD 358.1m−TWD 269.6m−TWD 286.4mTWD 617.8mTWD 2.01bnTWD 1.16bn
Capital spending−TWD 208.2m−TWD 178.5m−TWD 157.2m−TWD 7.5m−TWD 6.7m−TWD 72.8m−TWD 622.1m−TWD 1.66bn−TWD 2.99bn−TWD 1.66bn
Free cash flow−TWD 181.1mTWD 216.2m−TWD 1.12bn−TWD 197.4m−TWD 364.8m−TWD 342.4m−TWD 908.6m−TWD 1.04bn−TWD 977.3m−TWD 502.8m
Dividends paid−TWD 540.3m−TWD 1.03bn−TWD 589.9m−TWD 1.75bn−TWD 1.05bn−TWD 623.7m−TWD 525.4m−TWD 1.50bn−TWD 177.7m−TWD 117.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 432.1mTWD 466.0mTWD 399.5mTWD 359.1mTWD 378.7mTWD 378.9mTWD 448.6mTWD 392.5m
Gross profitTWD 188.6mTWD 217.1mTWD 167.6mTWD 143.7mTWD 146.7mTWD 163.3mTWD 211.2mTWD 182.1m
Operating incomeTWD 485.5m———TWD 2.8m—TWD 71.0mTWD 65.1m
Net income−TWD 10.45bnTWD 1.97bnTWD 6.78bnTWD 2.72bn−TWD 726.5mTWD 549.1m−TWD 763.5mTWD 273.3m
Diluted earnings per share-13.212.518.653.51-0.940.76-1.090.39
Cash from operationsTWD 21.0mTWD 120.0mTWD 94.0mTWD 46.0m−TWD 134.0mTWD 20.0mTWD 179.0mTWD 115.0m
Capital spending−TWD 32.0m−TWD 24.0m−TWD 65.0m−TWD 34.0m−TWD 89.0m−TWD 18.0m−TWD 57.0m−TWD 27.0m
Free cash flow−TWD 11.0mTWD 96.0mTWD 29.0mTWD 12.0m−TWD 223.0mTWD 2.0mTWD 122.0mTWD 88.0m
Total assetsTWD 23.97bnTWD 37.73bnTWD 34.63bnTWD 25.81bnTWD 23.67bnTWD 25.55bnTWD 25.54bnTWD 26.03bn
DebtTWD 3.74bnTWD 638.6mTWD 1.77bnTWD 1.71bnTWD 1.20bnTWD 2.77bnTWD 2.65bnTWD 2.43bn
Shareholders' equityTWD 17.16bnTWD 28.34bnTWD 26.49bnTWD 19.64bnTWD 16.80bnTWD 18.63bnTWD 18.05bnTWD 19.28bn

Financial ratios

Data as of 22 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin41.0%46.3%44.3%52.9%51.9%48.9%—
Operating margin—14.5%-5.7%17.2%209.9%52.0%13.8%
Net margin614.9%-68.2%-75.2%-75.0%363.2%528.1%—
Return on equity35.2%-6.1%-5.3%-3.0%9.6%21.1%—
Return on assets26.9%-4.3%-3.9%-2.3%6.0%13.6%—
Free cash flow yield—2.6%-3.8%-0.9%-1.9%-1.1%1.9%
Revenue growth-6.3%16.1%81.6%53.5%-30.3%-50.1%—
Earnings growth-944.7%5.3%82.0%-131.7%-52.0%-1959.9%—
Current ratio0.45x0.82x2.78x0.73x4.06x0.52x—
Debt to equity0.07x0.15x0.28x0.18x0.28x0.21x—
Equity ratio76.5%70.7%73.2%76.4%62.2%64.5%—
Interest coverage—1.03x-0.40x1.60x10.22x4.47x1.85x
R&D as a share of sales5.6%4.4%5.9%6.1%15.1%18.0%—
Buybacks as a share of market value—-2.0%-4.9%-7.9%-5.6%-1.3%-8.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue25.5%16.2%-13.9%
Net income—19.7%36.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin43.7%45.2%46.1%43.9%
Net margin262.3%124.5%187.3%26.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings3.3-25.2-26.3-44.214.56.8-104.03.151.5—
Price to sales20.517.219.833.152.636.214.70.90.71.0

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 3 Oct 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.7241.2970.8992.002
  • 1050-for-1000 split · 3 Oct 2025
  • 1050.6929-for-1000 split · 2 Oct 2025
  • 1101602.2-for-1000000 split · 8 Sept 2023
  • 1145.9683-for-1000 split · 8 Sept 2022
  • 1099.717-for-1000 split · 13 Sept 2021
  • 1047.554-for-1000 split · 6 Aug 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.